InVivo Therapeutics Holdings Corp. (NVIV) |
|
7.12 -0.09 (-1.25%)
|
02-14 16:00 |
|
Open: |
7.18 |
Pre. Close: |
7.21 |
|
High:
|
7.8 |
Low:
|
6.75 |
|
Volume:
|
159,293 |
Market Cap:
|
4M |
|
|
|
|
InVivo Therapeutics Holdings Corp is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
7.808 - 7.851 |
7.851 - 7.886 |
|
Low:
|
6.658 - 6.705 |
6.705 - 6.745 |
|
Close:
|
7.045 - 7.121 |
7.121 - 7.184 |
|
Technical analysis |
as of: 2020-02-14 4:31:14 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 9.94 One year: 11.61 |
| Support: |
Support1: 3.36 Support2: 0.17 |
| Resistance: |
Resistance1: 8.51 Resistance2: 9.94 |
| Pivot: |
1.68  |
| Moving Average: |
MA(5): 4.58 MA(20): 1.34
MA(100): 0.54 MA(250): 0.83 |
| MACD: |
MACD(12,26): 1.34 Signal(9): 0.51 |
| Stochastic oscillator: |
%K(14,3): 87.41 %D(3): 73.47 |
| RSI: |
RSI(14): 87.25  |
| 52-week: |
High: 8.51 Low: 0.12 Change(%): 405.0 |
| Average Vol(K): |
3-Month: 132818 10-Days: 98720 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.NVIV has closed below upper band by 3.1%. Bollinger Bands are 2398.6% wider than normal. The large width of the bands suggest high volatility as compared to NVIV's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2020-02-03
InVivo Therapeutics Announces Reverse Stock Split
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced a 1-for-30 reverse stock split of its common stock and a proportionate reduction in its authorized common stock. The company anticipates the reverse stock split will become effective at 5:00 p.m. Eastern Time on February 11, 2020, and shares of InVivo Therapeutics common stock will trade on a post-split basis under the Company's existing trading symbol, "NVIV," at the market open on February 12,
2019-11-26
The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Arvinas Inc (NASDAQ: ARVN ) (Guggenheim initiated coverage of stock with Buy rating and $50 price target) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) (announced achievement of enrollment target in a Phase 3 trial of drug to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) BIO-TECHNE Corp (NASDAQ: TECH ) BioNTech SE – ADR (NASDAQ: BNTX ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Cue Biopharma Inc (NASDAQ: CUE ) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Epizyme Inc (NASDAQ: EPZM ) ESSA Pharma Inc (NASDAQ: EPIX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Globus Medical Inc (NYSE: GMED ) Halozyme Therapeutics, Inc.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Global Market |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
16.52 |
| Shares Float (M) |
9.44 |
|
% Held by Insiders
|
0.77 |
|
% Held by Institutions
|
6.93 |
|
Shares Short (K)
|
234 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-1.184 |
|
Book Value (p.s.)
|
0.820 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-45.1 |
|
Return on Equity (ttm)
|
-83.4 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-0.709 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-11.41 |
|
Levered Free Cash Flow (M)
|
-7.45 |
Stock Valuations |
|
P/E
|
-6.01 |
|
P/E Growth Ratio
|
-0.01 |
|
P/BV
|
8.68 |
|
P/S
|
|
|
P/CF
|
-10.31 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2018-04-16 |
|
Last Split Ratio
|
0.04 |
|
7 Binary Options
|
|
Your Ad Here
|
|
